Tonabersat clinical trials
Also written SB220453.
- studies test it
- 5
- open now
- 0
- in phase 3
- 0
- first study started
- 2006
How each study uses tonabersat is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
5 studies that test it; most in 2006 (2)
| Year | Studies |
|---|---|
| 2006 | 2 |
| 2007 | 1 |
| 2023 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 5
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 1
Minster Research Ltd (3) · Jaeb Center for Health Research (1) · Inflammx Therapeutics Inc (1)
Studies
Open first, then newest update. How each study uses tonabersat is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- Evaluation of Tonabersat for DMECompletedPhase 2Jaeb Center for Health ResearchNCT05727891Written as TonabersatHow we know
- Study of Xiflam™ Treatment in Patients Post COVID-19 Infection Suffering From What is Known as Long COVID (LC)CompletedPhase 2Inflammx Therapeutics IncNCT06437223Written as TonabersatHow we know
- Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine HeadacheCompletedPhase 2Minster Research LtdNCT00311662Written as TonabersatHow we know
- Tonabersat in the Prophylaxis of Migraine With AuraCompletedPhase 2Minster Research LtdNCT00332007Written as TonabersatHow we know
- Dose Ranging Study of the Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine HeadacheCompletedPhase 2Minster Research LtdNCT00534560Written as TonabersatHow we know
What changed recently
From the registry's own updates since Oct 23, 2026.
Results posted1
- Evaluation of Tonabersat for DMENov 20, 2026NCT05727891
Codes
What other systems call tonabersat · ClinicalTrials.gg INT004148
- MeSH (NLM) C118706tonabersatConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 2XD9773ZMNTONABERSATConfirmed FDA, NLM, Wikidata
- Wikidata Q27255763tonabersatConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C97277TonabersatOne source FDA
- DrugBank DB06578One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C118706 | tonabersat | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 2XD9773ZMN | TONABERSAT | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27255763 | tonabersat | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C97277 | Tonabersat | One source FDA |
| DrugBank | DB06578 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.